Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

1.

Mapping Tumor Hypoxia In Vivo Using Pattern Recognition of Dynamic Contrast-enhanced MRI Data.

Stoyanova R, Huang K, Sandler K, Cho H, Carlin S, Zanzonico PB, Koutcher JA, Ackerstaff E.

Transl Oncol. 2012 Dec;5(6):437-47. Epub 2012 Dec 1.

PMID:
23326621
[PubMed]
Free PMC Article
2.

Gaussian mixture model-based classification of dynamic contrast enhanced MRI data for identifying diverse tumor microenvironments: preliminary results.

Han SH, Ackerstaff E, Stoyanova R, Carlin S, Huang W, Koutcher JA, Kim JK, Cho G, Jang G, Cho H.

NMR Biomed. 2013 May;26(5):519-32. doi: 10.1002/nbm.2888. Epub 2013 Feb 25.

PMID:
23440683
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Assessment of tumor necrotic fraction by dynamic contrast-enhanced MRI: a preclinical study of human tumor xenografts with histopathologic correlation.

Koh TS, Thng CH, Hartono S, Dominguez LT, Lim TK, Huynh H, Martarello L, Ng QS.

NMR Biomed. 2014 Apr;27(4):486-94. doi: 10.1002/nbm.3090. Epub 2014 Feb 17.

PMID:
24535773
[PubMed - in process]
4.

Free-breathing quantitative dynamic contrast-enhanced magnetic resonance imaging in a rat liver tumor model using dynamic radial T(1) mapping.

Braren R, Curcic J, Remmele S, Altomonte J, Ebert O, Rummeny EJ, Steingoetter A.

Invest Radiol. 2011 Oct;46(10):624-31. doi: 10.1097/RLI.0b013e31821e30e7.

PMID:
21577121
[PubMed - indexed for MEDLINE]
5.

Noninvasive multimodality imaging of the tumor microenvironment: registered dynamic magnetic resonance imaging and positron emission tomography studies of a preclinical tumor model of tumor hypoxia.

Cho H, Ackerstaff E, Carlin S, Lupu ME, Wang Y, Rizwan A, O'Donoghue J, Ling CC, Humm JL, Zanzonico PB, Koutcher JA.

Neoplasia. 2009 Mar;11(3):247-59, 2p following 259.

PMID:
19242606
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.

Wilmes LJ, Pallavicini MG, Fleming LM, Gibbs J, Wang D, Li KL, Partridge SC, Henry RG, Shalinsky DR, Hu-Lowe D, Park JW, McShane TM, Lu Y, Brasch RC, Hylton NM.

Magn Reson Imaging. 2007 Apr;25(3):319-27. Epub 2007 Feb 5.

PMID:
17371720
[PubMed - indexed for MEDLINE]
7.

Region of interest and pixel-by-pixel analysis of dynamic contrast enhanced magnetic resonance imaging parameters and time-intensity curve shapes: a comparison in chondroid tumors.

Lavini C, Pikaart BP, de Jonge MC, Schaap GR, Maas M.

Magn Reson Imaging. 2009 Jan;27(1):62-8. doi: 10.1016/j.mri.2008.05.012. Epub 2008 Jul 11.

PMID:
18619754
[PubMed - indexed for MEDLINE]
8.

Peripheral washout phenomenon in an animal tumour model: comparison of dynamic magnetic resonance imaging using a small molecular contrast medium with histology.

Drees R, Hünigen H, Wagner S, Schnorr J, Plendl J, Taupitz M.

Vet Comp Oncol. 2008 Sep;6(3):151-61. doi: 10.1111/j.1476-5829.2007.00156.x.

PMID:
19178675
[PubMed - indexed for MEDLINE]
9.

Preoperative dynamic contrast-enhanced MRI correlates with molecular markers of hypoxia and vascularity in specific areas of intratumoral microenvironment and is predictive of patient outcome.

Jensen RL, Mumert ML, Gillespie DL, Kinney AY, Schabel MC, Salzman KL.

Neuro Oncol. 2014 Jan;16(2):280-91. doi: 10.1093/neuonc/not148. Epub 2013 Dec 4.

PMID:
24305704
[PubMed - in process]
10.

Dynamic contrast-enhanced magnetic resonance imaging of tumors: preclinical validation of parametric images.

Egeland TA, Simonsen TG, Gaustad JV, Gulliksrud K, Ellingsen C, Rofstad EK.

Radiat Res. 2009 Sep;172(3):339-47. doi: 10.1667/RR1787.1.

PMID:
19708783
[PubMed - indexed for MEDLINE]
11.

Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI.

Chen W, Giger ML, Bick U, Newstead GM.

Med Phys. 2006 Aug;33(8):2878-87.

PMID:
16964864
[PubMed - indexed for MEDLINE]
12.

MR imaging of tumor microcirculation: promise for the new millennium.

Taylor JS, Tofts PS, Port R, Evelhoch JL, Knopp M, Reddick WE, Runge VM, Mayr N.

J Magn Reson Imaging. 1999 Dec;10(6):903-7.

PMID:
10581502
[PubMed - indexed for MEDLINE]
13.

Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer.

Røe K, Mikalsen LT, van der Kogel AJ, Bussink J, Lyng H, Ree AH, Marignol L, Olsen DR.

Radiat Oncol. 2012 May 23;7:75. doi: 10.1186/1748-717X-7-75.

PMID:
22621752
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Washout of small molecular contrast agent in carcinoma-derived experimental tumors.

Galiè M, Farace P, Merigo F, Fiorini S, Tambalo S, Nicolato E, Sbarbati A, Marzola P.

Microvasc Res. 2009 Dec;78(3):370-8. doi: 10.1016/j.mvr.2009.09.004. Epub 2009 Oct 3.

PMID:
19804787
[PubMed - indexed for MEDLINE]
15.

Noninvasive tumor hypoxia measurement using magnetic resonance imaging in murine U87 glioma xenografts and in patients with glioblastoma.

Linnik IV, Scott ML, Holliday KF, Woodhouse N, Waterton JC, O'Connor JP, Barjat H, Liess C, Ulloa J, Young H, Dive C, Hodgkinson CL, Ward T, Roberts D, Mills SJ, Thompson G, Buonaccorsi GA, Cheung S, Jackson A, Naish JH, Parker GJ.

Magn Reson Med. 2014 May;71(5):1854-62. doi: 10.1002/mrm.24826. Epub 2013 Jun 24.

PMID:
23798369
[PubMed - in process]
16.

Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma.

Rosen MA, Schnall MD.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):770s-776s. Review.

PMID:
17255308
[PubMed - indexed for MEDLINE]
Free Article
17.

Ytterbium chelated to 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid,10-orthoaminoanilide.

Pagel M, Chopra A.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2011 Nov 26 [updated 2012 Jan 05].

PMID:
22238803
[PubMed]
Books & Documents
18.

Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model.

Ceelen W, Smeets P, Backes W, Van Damme N, Boterberg T, Demetter P, Bouckenooghe I, De Visschere M, Peeters M, Pattyn P.

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1188-96. Epub 2006 Feb 2.

PMID:
16457965
[PubMed - indexed for MEDLINE]
19.

Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.

Liang J, Sammet S, Yang X, Jia G, Takayama Y, Knopp MV.

Invest Radiol. 2010 May;45(5):233-44. doi: 10.1097/RLI.0b013e3181d54507.

PMID:
20351653
[PubMed - indexed for MEDLINE]
20.

Quantitative analysis of dynamic contrast-enhanced MRI datasets of the metacarpophalangeal joints.

Kubassova OA, Boyle RD, Radjenovic A.

Acad Radiol. 2007 Oct;14(10):1189-200.

PMID:
17889336
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk